CIK 0000021665
- Large accelerated filer
COLGATE PALMOLIVE CO
Sign in to watch- Ticker
- CL
- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 131815595
- Phone
- +1 212-310-2000
- Business address
- 300 PARK AVE, NEW YORK, NY, 10022
- Former names
- COLGATE PALMOLIVE CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,027,828
- in 6 filings
Net −$8,027,828. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Tsourapas Panagiotis −$2.9M COO, CD, EMEA, APac, Skin sold 77% of stake
- Hazlin John −$2.3M Chief Growth Officer sold 46% of stake
- Wallace Noel R. −$2.0M Chairman, President & CEO sold 5% of stake
- NORRINGTON LORRIE M −$414K Director sold 9% of stake
- Malcolm Gregory −$402K EVP and Controller sold 29% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-04 | Massey Sally Chief Human Resources Officer | Exercise or conversion | +17,239 | $68.16 | $1.2M | 25,854 |
| 2023-05-04 | Massey Sally Chief Human Resources Officer | Sale | −17,239 | $81.16 | $1.4M | 8,615 |
| 2023-05-04 | Massey Sally Chief Human Resources Officer | Exercise or conversion · Stock Option (Right to Buy) | −17,239 | 0 | ||
| 2023-05-04 | Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts | Exercise or conversion | +20,000 | $73.00 | $1.5M | 26,906 |
| 2023-05-04 | Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts | Sale | −20,000 | $80.78 | $1.6M | 6,906 |
| 2023-05-04 | Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 13,698 | ||
| 2023-05-03 | SADOVE STEPHEN I Director | Exercise or conversion | +6,329 | $62.04 | $393K | 18,195 |
| 2023-05-03 | SADOVE STEPHEN I Director | Exercise or conversion | +5,703 | $71.65 | $409K | 23,898 |
| 2023-05-03 | SADOVE STEPHEN I Director | Sale | −12,032 | $81.37 | $979K | 11,866 |
| 2023-05-03 | SADOVE STEPHEN I Director | Exercise or conversion · Stock Option (Right to Buy) | −6,329 | 0 | ||
| 2023-05-03 | SADOVE STEPHEN I Director | Exercise or conversion · Stock Option (Right to Buy) | −5,703 | 0 | ||
| 2023-05-03 | Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts | Exercise or conversion | +35,000 | $73.00 | $2.6M | 41,906 |
| 2023-05-03 | Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts | Sale | −35,000 | $80.94 | $2.8M | 6,906 |
| 2023-05-03 | Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts | Exercise or conversion · Stock Option (Right to Buy) | −35,000 | 33,698 | ||
| 2023-04-03 | CAHILLANE STEVEN A Director | Grant or award | +257 | $72.95 | $19K | 257 |
| 2023-04-03 | BILBREY JOHN P Director | Grant or award | +291 | $72.95 | $21K | 26,257 |
| 2023-04-03 | Edwards Lisa Director | Grant or award | +128 | $72.95 | $9K | 7,124 |
| 2023-04-03 | NORRINGTON LORRIE M Director | Grant or award | +359 | $72.95 | $26K | 28,029 |
| 2023-03-13 | Kooyman John W Chief of Staff | Sale | −2,040 | $71.67 | $146K | 6,366 |
| 2023-02-27 | CAHILL JOHN T Director | Exercise or conversion | +5,703 | $71.65 | $409K | 30,086 |
Page 25 of 30 · 590 trades